EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Immunogenicity of a trivalent haemorrhagic fever vaccine candidate against Sudan virus, Marburg virus and Lassa virus in an mpox vaccine

Martina Pfranger, Nina Krause, Benedikt Asbach, Johannes Meier, George Carnell, Lara Scheer, Anja Kalender, David Brenner, Paul Tonks, Simon Frost, Edward Wright, Ingo Jordan und 12 weitere

Journal of General Virology · 2025

DOI: 10.1099/jgv.0.002157 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of General Virology, 2025. Verfasst von Martina Pfranger und 23 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Microbiology and Hygiene, University of Regensburg, Regensburg, Germany. Hauptthemen laut MEDLINE: Hemorrhagic Fevers, Viral, Immunogenicity, Vaccine, Lassa Fever, Lassa virus. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innovate UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A multivalent vaccine targeting high-consequence infectious diseases in Sub-Saharan Africa (SSA), which are linked to high mortality, morbidity and overlapping clinical manifestations, would significantly improve health security and economic stability in this region. Trivalent vector vaccines were devised to deliver digitally optimized versions of Orthoebolavirus, Orthomarburgvirus glycoproteins (GPs) and a Lassa mammarenavirus (LASV) nucleoprotein (NP) by a single Modified Vaccinia Ankara (MVA) known to protect against mpox virus (MPXV) along with a matched DNA vaccine. Three immunizations in mice and Hartley guinea pigs with MVA only or a DNA prime followed by two MVA administrations induced comparable levels of binding antibodies and LASV-specific T-cells, respectively. While DNA priming mitigated MVA-specific antibody responses, GP- and NP-specific antibodies developed already after a single MVA vaccination. Although a post-outbreak Ebola virus vaccine is available, outbreaks by other filoviruses, annual LASV epidemics and increased incidence of MPXV infections support the rationale for an MVA-based trivalent haemorrhagic fever vaccine for endemic and high-risk human populations in SSA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hemorrhagic Fevers, ViralImmunogenicity, VaccineLassa FeverLassa virusMarburgvirusSmallpox VaccineAnimalsFemaleGuinea PigsMiceAntibodies, ViralMarburg Virus DiseaseVaccines, DNA

Stichwörter der Autor:innen

Modified Vaccinia Ankara (MVA)haemorrhagic fever virusesmultivalent vaccine

Substanzen

Antibodies, ViralSmallpox VaccineVaccines, DNA

Autor:innen und Institutionen

  • Institute of Medical Microbiology and Hygiene, University of Regensburg, Regensburg, Germany.
  • Department of Veterinary Medicine, Lab of Viral Zoonotics, University of Cambridge, Cambridge, UK.
  • One Virology, Wolfson Centre for Global Virus Research, School of Veterinary Medicine and Science, University of Nottingham, Nottingham, UK.
  • DIOSynVax Ltd™, Cambridge, UK.
  • Microsoft Health Futures, Redmond, USA.
  • London School of Hygiene and Tropical Medicine, London, UK.

Förderung

  • Innovate UK

Zitieren

APA

Pfranger, M., Krause, N., Asbach, B., Meier, J., Carnell, G., Scheer, L., Kalender, A., Brenner, D., Tonks, P., Frost, S., Wright, E., Jordan, I., Kennedy, E., Hewson, R., Blacklaws, B., Chan, A., Parthasarathy, S., Dowall, S., Carroll, M., …, & Wagner, R. (2025). Immunogenicity of a trivalent haemorrhagic fever vaccine candidate against Sudan virus, Marburg virus and Lassa virus in an mpox vaccine. Journal of General Virology. https://doi.org/10.1099/jgv.0.002157

Vancouver

Pfranger M, Krause N, Asbach B, Meier J, Carnell G, Scheer L, et al. Immunogenicity of a trivalent haemorrhagic fever vaccine candidate against Sudan virus, Marburg virus and Lassa virus in an mpox vaccine. Journal of General Virology. 2025. doi:10.1099/jgv.0.002157

BibTeX
@article{Pfranger2025,
  author = {Pfranger, Martina and Krause, Nina and Asbach, Benedikt and Meier, Johannes and Carnell, George and Scheer, Lara and Kalender, Anja and Brenner, David and Tonks, Paul and Frost, Simon and Wright, Edward and Jordan, Ingo and Kennedy, Emma and Hewson, Roger and Blacklaws, Barbara and Chan, Andrew and Parthasarathy, Srivatsan and Dowall, Stuart and Carroll, Miles and Sandig, Volker and Fedosyuk, Sofiya and Kinsley, Rebecca and Heeney, Jonathan and Wagner, Ralf},
  title = {Immunogenicity of a trivalent haemorrhagic fever vaccine candidate against Sudan virus, Marburg virus and Lassa virus in an mpox vaccine},
  journal = {Journal of General Virology},
  year = {2025},
  doi = {10.1099/jgv.0.002157}
}
Kostenlos starten →